QuantumDx
The firm's dielectrophoresis technology captures and holds cellular targets so they can be identified more easily in molecular tests or microscopy.
In Brief This Week: Meridian Bioscience, BioMérieux, Applied DNA Sciences, More
News items for the week of Dec. 12, 2022.
Menarini to Distribute QuantuMDx Point-of-Care MDx System, Tests in UK and France
The deal includes QuantuMDx's recently launched assays for SARS-CoV-2, influenza, and respiratory syncytial virus.
QuantuMDx Obtains CE Mark for 30-Minute Multiplex Respiratory Panel
The panel, which tests for flu, respiratory syncytial virus, and SARS-CoV-2, expands the company's menu for the molecular Q-POC platform.
In Brief This Week: Labcorp, QuantuMDx, PerkinElmer, Bruker, Pathomics Health, More
News items for the week of March 7, 2022.
Feb 12, 2020
Dec 10, 2019
Ontera, QuantuMDx Partner on Sepsis Test Development
Jan 24, 2018
QuantuMDx Raises $12M
Nov 28, 2016
Oct 28, 2014